Paul R Michl

Array ( [id] => 3818614 [patent_doc_number] => 05770700 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Liquid factor IX formulations' [patent_app_type] => 1 [patent_app_number] => 8/591332 [patent_app_country] => US [patent_app_date] => 1996-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5229 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770700.pdf [firstpage_image] =>[orig_patent_app_number] => 591332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002592 [patent_doc_number] => 05858972 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Antithrombotic agents and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/585281 [patent_app_country] => US [patent_app_date] => 1996-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 8620 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858972.pdf [firstpage_image] =>[orig_patent_app_number] => 585281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3833201 [patent_doc_number] => 05814610 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Osteogenic growth oligopeptides and pharmaceutical compositions containing them' [patent_app_type] => 1 [patent_app_number] => 8/530277 [patent_app_country] => US [patent_app_date] => 1996-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 12 [patent_no_of_words] => 4936 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814610.pdf [firstpage_image] =>[orig_patent_app_number] => 530277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4179328 [patent_doc_number] => 06037324 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor' [patent_app_type] => 1 [patent_app_number] => 8/582740 [patent_app_country] => US [patent_app_date] => 1996-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 22893 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037324.pdf [firstpage_image] =>[orig_patent_app_number] => 582740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3763535 [patent_doc_number] => 05844074 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Cyclic CRF agonists' [patent_app_type] => 1 [patent_app_number] => 8/575148 [patent_app_country] => US [patent_app_date] => 1995-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24970 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/844/05844074.pdf [firstpage_image] =>[orig_patent_app_number] => 575148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158011 [patent_doc_number] => 06107459 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Technetium-99m labeled peptides for diagnostic imaging' [patent_app_type] => 1 [patent_app_number] => 8/505318 [patent_app_country] => US [patent_app_date] => 1995-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9915 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107459.pdf [firstpage_image] =>[orig_patent_app_number] => 505318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3759699 [patent_doc_number] => 05721338 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-24 [patent_title] => 'Inhibitors of oligosaccharyl transferase' [patent_app_type] => 1 [patent_app_number] => 8/568486 [patent_app_country] => US [patent_app_date] => 1995-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6589 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/721/05721338.pdf [firstpage_image] =>[orig_patent_app_number] => 568486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3740333 [patent_doc_number] => 05753619 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Composition for prophylaxis or treatment of pulmonary circulatory diseases' [patent_app_type] => 1 [patent_app_number] => 8/564442 [patent_app_country] => US [patent_app_date] => 1995-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12851 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753619.pdf [firstpage_image] =>[orig_patent_app_number] => 564442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690814 [patent_doc_number] => 05691455 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Gonadotropins with non-native disulfide bridges' [patent_app_type] => 1 [patent_app_number] => 8/556114 [patent_app_country] => US [patent_app_date] => 1995-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5420 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691455.pdf [firstpage_image] =>[orig_patent_app_number] => 556114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623042 [patent_doc_number] => 05688912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Peptide ligands which bind to von willebrand factor' [patent_app_type] => 1 [patent_app_number] => 8/537069 [patent_app_country] => US [patent_app_date] => 1995-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6370 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688912.pdf [firstpage_image] =>[orig_patent_app_number] => 537069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725801 [patent_doc_number] => 05681925 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Trifunctional antithrombin and antiplatelet peptides' [patent_app_type] => 1 [patent_app_number] => 8/502989 [patent_app_country] => US [patent_app_date] => 1995-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15688 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681925.pdf [firstpage_image] =>[orig_patent_app_number] => 502989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3892764 [patent_doc_number] => 05834588 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => '(Cyanomethylene) phosphoranes as carbonyl 1,1-dipole synthons for use in constructing combinatorial libraries' [patent_app_type] => 1 [patent_app_number] => 8/503070 [patent_app_country] => US [patent_app_date] => 1995-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8416 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834588.pdf [firstpage_image] =>[orig_patent_app_number] => 503070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850443 [patent_doc_number] => 05767071 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Sevenmer cyclic peptide inhibitors of diseases involving .alpha..sub.v .beta..sub.3' [patent_app_type] => 1 [patent_app_number] => 8/482106 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18242 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767071.pdf [firstpage_image] =>[orig_patent_app_number] => 482106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3760847 [patent_doc_number] => 05843901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'LHRH antagonist peptides' [patent_app_type] => 1 [patent_app_number] => 8/480494 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16350 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843901.pdf [firstpage_image] =>[orig_patent_app_number] => 480494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871443 [patent_doc_number] => 05763406 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Method for the treatment of conditions caused by herpes virus infections' [patent_app_type] => 1 [patent_app_number] => 8/481840 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3416 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763406.pdf [firstpage_image] =>[orig_patent_app_number] => 481840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787170 [patent_doc_number] => 05840691 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Method for treating ischemia using polypeptides with fibronectin activity' [patent_app_type] => 1 [patent_app_number] => 8/480133 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 26 [patent_no_of_words] => 13622 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840691.pdf [firstpage_image] =>[orig_patent_app_number] => 480133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4203941 [patent_doc_number] => 06027811 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Thin-wall intraluminal graft' [patent_app_type] => 1 [patent_app_number] => 8/486124 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 19 [patent_no_of_words] => 5521 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/027/06027811.pdf [firstpage_image] =>[orig_patent_app_number] => 486124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048379 [patent_doc_number] => 05968904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Modified arginine containing lytic peptides and method of making the same by glyoxylation' [patent_app_type] => 1 [patent_app_number] => 8/475328 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5878 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968904.pdf [firstpage_image] =>[orig_patent_app_number] => 475328 [rel_patent_id] =>[rel_patent_doc_number] =>)